Explain this page
Arphra AIPlain-English read on Edwards Lifesciences Corporation’s valuation06-12today
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$69.69
-21.48% vs spot
Recommendation
Sell
15 of 16 methods
Method spread
2bull11bear
±5% threshold
Analyst PT consensus: $96.53 (+8.76%)
Candlestick · 1Y
Open in chart workstation →EW
86.28+15.32%H 89.48L 72.30MA50 82.42MA200 81.78Avg vol 4.5M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.84% | +3.11% | +9.03% | +6.19% | +4.00% | +4.08% | +18.59% | -3.49% | -11.39% | +168.04% | +6353.09% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$3.83M
10 txns
Net flow
−$3.83M
Aftermarket
LiveLast trade
$88.75
324 sh
Bid
$88.73
60 sh
Ask
$88.80
200 sh
Spread
$0.070
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $1.65B | $380.7M | $0.66 |
| Q4 Dec 2025 | $1.57B | $91.2M | $0.16 |
| Q3 Sep 2025 | $1.55B | $291.1M | $0.50 |
| Q2 Jun 2025 | $1.53B | $329.8M | $0.56 |
| Q1 Mar 2025 | $1.41B | $358M | $0.61 |
| Q4 Dec 2024 | $1.39B | $385.6M | $0.65 |
Sector & industry today
LiveSectors
- Industrials+0.85%
- Utilities+0.80%
- Basic Materials+0.69%
- Consumer Cyclical+0.38%
- Energy+0.26%
- Consumer Defensive+0.20%
- Technology+0.08%
- Real Estate-0.02%
- Financial Services-0.59%
- Healthcare-0.88%
- Communication Services-1.16%
Top industries (issuer's industry highlighted)
- Medical - Devices+0.02%
- Solar-4.85%
- Travel Services+2.61%
- Independent Power Producers+2.50%
- Auto - Dealerships+2.19%
- Electronic Gaming & Multimedia+1.81%
- Construction Materials+1.59%
- Steel-1.54%
- Home Improvement+1.53%
- Broadcasting-1.38%
- Engineering & Construction+1.29%
- Business Equipment & Supplies+1.24%
Analyst view
DB · price_targets + analyst_gradesConsensus target
$96.53
+8.76% upside
Low
$85.00
Median
$95.00
High
$110.00
Recent actions
0 ↑0 ↓8 hold
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
- Dec 01, 2025
News
DB · news_items- Should You Continue to Hold EW Stock in Your Portfolio?zacks.com·Jun 12, 2026
- East West Announces $858,000 Non-Brokered Private Placementnewsfilecorp.com·Jun 12, 2026
- East West Announces $858,000 Non-Brokered Private Placementnewsfilecorp.com·Jun 12, 2026
- Edwards Lifesciences Corporation (EW) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.com·May 12, 2026
- Edwards Lifesciences Announces Appointment of CFObusinesswire.com·May 04, 2026
- Edwards Lifesciences Announces Appointment of CFObusinesswire.com·May 04, 2026
- Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences' Resilia Tissuebusinesswire.com·May 02, 2026
- Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences' Resilia Tissuebusinesswire.com·May 02, 2026
Recent analyst activity
DB- Jun 02, 2026GradeBuy → Buy'Edwards Lifesciences (EW) is our new Top-Pick'; PT Raised at TD CowenCowen & Co.
Peers
Total assets
$13.7B
Total debt
$705.4M
Cash & equiv
$2.94B
Operating CF
$1.6B
Free cash flow
$1.34B
Buybacks
-$893.4M
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Markowitz Wayne officer: CVP, JAPAC | Sell | 593 | $47.28K | May 11, 2026 |
Lippis Daniel J. officer: CVP, TAVR | Sell | 1,019 | $85.58K | May 04, 2026 |
Lippis Daniel J. officer: CVP, TAVR | Sell | 19 | $1.6K | May 01, 2026 |
Lippis Daniel J. officer: CVP, TAVR | Sell | 1,000 | $82.99K | May 01, 2026 |
Ullem Scott B. officer: CVP, Chief Financial Officer | Sell | 4,676 | $376.4K | Apr 09, 2026 |
Ullem Scott B. officer: CVP, Chief Financial Officer | Sell | 8,324 | $664.14K | Apr 09, 2026 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $6.07B | $1.64B | $1.07B | $1.83 | +17.69% |
| FY 2024 | $5.44B | $1.38B | $4.17B | $6.97 | +76.75% |
| FY 2023 | $5.01B | $1.43B | $1.4B | $2.30 | +27.99% |
| FY 2022 | $5.38B | $1.7B | $1.52B | $2.44 | +28.28% |
| FY 2021 | $5.23B | $1.61B | $1.5B | $2.38 | +28.73% |